Jane Street Group LLC acquired a new position in shares of Ingevity Corp (NYSE:NGVT) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,226 shares of the company’s stock, valued at approximately $261,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Greenwood Capital Associates LLC increased its holdings in shares of Ingevity by 12.6% during the 2nd quarter. Greenwood Capital Associates LLC now owns 4,609 shares of the company’s stock worth $373,000 after buying an additional 516 shares during the last quarter. State Board of Administration of Florida Retirement System increased its holdings in Ingevity by 2.1% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 25,772 shares of the company’s stock valued at $2,084,000 after purchasing an additional 530 shares in the last quarter. First Midwest Bank Trust Division increased its holdings in Ingevity by 13.0% in the 2nd quarter. First Midwest Bank Trust Division now owns 4,776 shares of the company’s stock valued at $386,000 after purchasing an additional 551 shares in the last quarter. Alps Advisors Inc. increased its holdings in Ingevity by 4.5% in the 2nd quarter. Alps Advisors Inc. now owns 14,729 shares of the company’s stock valued at $1,191,000 after purchasing an additional 629 shares in the last quarter. Finally, Metropolitan Life Insurance Co. NY increased its holdings in Ingevity by 5.3% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 13,642 shares of the company’s stock valued at $1,103,000 after purchasing an additional 681 shares in the last quarter. Institutional investors and hedge funds own 92.04% of the company’s stock.

Shares of NYSE NGVT opened at $88.63 on Friday. The company has a debt-to-equity ratio of 2.09, a current ratio of 2.58 and a quick ratio of 1.48. The firm has a market capitalization of $3.78 billion, a P/E ratio of 34.78, a P/E/G ratio of 2.01 and a beta of 1.22. Ingevity Corp has a 12-month low of $66.57 and a 12-month high of $106.59.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, July 25th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.13. The company had revenue of $308.60 million during the quarter, compared to analysts’ expectations of $305.14 million. Ingevity had a net margin of 14.72% and a return on equity of 46.65%. The firm’s revenue for the quarter was up 18.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.78 EPS. On average, analysts forecast that Ingevity Corp will post 3.72 earnings per share for the current year.

NGVT has been the subject of several recent research reports. Zacks Investment Research downgraded Ingevity from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 25th. Berenberg Bank downgraded Ingevity from a “buy” rating to a “hold” rating and set a $110.00 price target for the company. in a report on Tuesday, October 2nd. KeyCorp increased their price target on Ingevity from $95.00 to $110.00 and gave the company an “overweight” rating in a report on Friday, July 27th. Loop Capital set a $98.00 price target on Ingevity and gave the company a “hold” rating in a report on Thursday, August 16th. Finally, Jefferies Financial Group increased their price target on Ingevity to $102.00 and gave the company a “buy” rating in a report on Tuesday, July 17th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $101.44.

Ingevity Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems.

Recommended Story: Yield Curve

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.